| Richa Parag Sheth, MD | |
|
Helix: 30 N Mario Capecchi Dr Rm 3n100, Salt Lake City, UT 84112 | |
| (801) 581-2121 | |
| Not Available |
| Full Name | Richa Parag Sheth |
|---|---|
| Gender | Female |
| Speciality | Internal Medicine - Pulmonary Disease |
| Location | Helix: 30 N Mario Capecchi Dr Rm 3n100, Salt Lake City, Utah |
| Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1013593458 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207RC0200X | Internal Medicine - Critical Care Medicine | 13896273-1205 (Utah) | Secondary |
| 207RP1001X | Internal Medicine - Pulmonary Disease | 13896273-1205 (Utah) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Richa Parag Sheth, MD Helix: 30 N Mario Capecchi Dr Rm 3n100, Salt Lake City, UT 84112 Ph: (801) 581-2121 | Richa Parag Sheth, MD Helix: 30 N Mario Capecchi Dr Rm 3n100, Salt Lake City, UT 84112 Ph: (801) 581-2121 |
News Archive
Decision Resources, one of the world's leading research and advisory firms focusing on pharmaceutical and healthcare issues, finds that compared to last year's analysis of U.S. patient-level claims data, TNF-alpha inhibitors are being used more often to treat newly diagnosed patients suffering from Crohn's disease.
Oregon Health & Science University is part of a national research project investigating stem cell therapy as a potential treatment for glaucoma, the world's second leading cause of blindness.
The U.S. Government has proposed major changes in the rules covering research involving human subjects. Officials believe this would strengthen protections while reducing red tape that can impede studies. The experts cited vastly altered research climate as reasons for these recommendations. New features include genomics studies using patients' DNA samples, the use of the Internet and a growing reliance on studies that take place at many sites at once. The new rules cover topics like the informed consent that research participants must provide and the institutional review boards that oversee research at universities and hospitals.
An analysis of comparative effectiveness studies finds that few compare medications with nonpharmacologic interventions, and few examine safety or cost-effectiveness, according to a study in the March 10 issue of JAMA.
› Verified 6 days ago
Dr. Mehmet Akkaya, M.D Pulmonary Disease Medicare: Medicare Enrolled Practice Location: University Of Utah Hospital Cardiology, 3o N,1900 E, Rm:4a100, Salt Lake City, UT 84132 Phone: 801-505-1689 | |
Dr. Willard Dere, M.D. Pulmonary Disease Medicare: Not Enrolled in Medicare Practice Location: 500 Foothill Blvd, Salt Lake City, UT 84148 Phone: 801-582-1565 | |
Megan Meier, MD Pulmonary Disease Medicare: Medicare Enrolled Practice Location: 50 N Medical Dr, Salt Lake City, UT 84132 Phone: 801-581-2121 | |
Joel Money, MD Pulmonary Disease Medicare: Medicare Enrolled Practice Location: 50 N Medical Dr, Salt Lake City, UT 84132 Phone: 801-581-2121 | |
Mchale O. Anderson, MD Pulmonary Disease Medicare: Medicare Enrolled Practice Location: 30 N 1900 E Rm 4a100, Salt Lake City, UT 84132 Phone: 801-587-2451 | |
Siddharth K. Iyengar, MD Pulmonary Disease Medicare: Medicare Enrolled Practice Location: 30 N 1900 E Rm 4c116, Salt Lake City, UT 84132 Phone: 801-581-7606 | |
Taryn A. Young, MD Pulmonary Disease Medicare: Medicare Enrolled Practice Location: 5121 S Cottonwood St, Salt Lake City, UT 84107 Phone: 801-507-4384 Fax: 801-507-4398 |